Axillary recurrence in sentinel lymph node-negative breast cancer patients

Annals of Oncology

Volumn 19, Issue 11, 2008, Pages 1842-1846

  Poletti, P ^a   Fenaroli, P ^a   Milesi, A ^a   Paludetti, A ^a   Mangiarotti, S ^a   Virotta, G ^a   Candiago, E ^a   Bettini, A ^a   Caremoli, E R ^a   Labianca, R ^a   Tondini, C ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

Axillary lymph node recurrence; Breast cancer; Sentinel lymph node biopsy

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RECURRENT CANCER; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; SENTINEL LYMPH NODE BIOPSY;

EID: 54949153148     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn393     Document Type: Article

References (35)

1. Early stage breast cancer. Consens Statement 1990; 8: 1-19.
2. Harris A Osteen RT. Patients with early breast cancer benefit from effective axillary treatment. Breast Canoer Res Treat 1985; 5: 17-21.
3. Giuliano AE, Haigh PI, Brennan MB et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patents with sentinel node-negatve breast cancer. J Clin Oncoll 2000; 18: 2553-2559.
4. Veronesi U, Paganelli G, Viale G et al. A randomized comparison of sentinel node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349: 546-553.
5. Fenaroli P, Merson M, Giuliano L et al. Population-based sentinel lymph node biopsy in early invasive breast cancer. Eur J Surg Oncol 2004; 30: 618-623.
6. Schwartz GF, Giuliano AE, Veronesi U, the Consensus Conference Committee. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, PA. Cancer 2002; 94: 2542-2551.
7. Veronesi U, Orecchia R, Luini A et al. Full dose intraolperadve radiotherapy with electrons during breast conserving surgery. Experience with 590 cases. Ann Surg 2005; 242(1): 101-106.
8. Goldhirsch A, Wood WC, Gelber RD et al. 10th St. Gallen Conference. Progress and promise: Highlight of the internatonal expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 2007; 18(7): 1133-1144.
9. Veronesi U, Paganelli G, Viale G et al. Sentinel lymph node biopsy as staging procedure in breast cancer: Update of a randomized controlled study. Lancet Oncol 2006; 7: 983-990.
10. Schulze T, Mucke J, Markwardt J et al. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol 2006; 93: 109-119.
11. Krag D, Weaver D, Ashikaga T et al. The sentinel node in breast cancer, multicenter validation study. N Engl J Med 1998; 339: 941-946.
12. Classe JM, Curtet C, Campion L at al. Learning curve for the detection of axillary sentinel lymph node in breast cancer. Eur J Surg Oncol 2003; 29: 426-433.
13. Harlow SP, Krag DN. Sentinel lymph node: Why study it? Implications of the B-32 study. Semin Surg Oncol 2001; 20: 224-229.
14. Giuliano AE, Haigh PI, Brennan MB et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000; 18: 2553-2559.
15. Roumen RM, Kuijt GP, Liem IH, van Beek MW. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg 2001; 88: 1639-1643.
16. Veronesi U, Galimberti V. Zurrida S et al. Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer 2001; 37: 454-458.
17. Chung MA, Steinhoff MM, Cady B. Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy. Am J Surg 2002; 184: 310-314.
18. Reitsamer R, Peintinger F, Prokop E et al. Sentinel lymph node biopsy alone without axillary lymph node dissection- follow up of sentinel lymph node negative breast cancer patients. Eur J Surg Oncol 2003; 29: 221-223.
19. Blanchard DK, Donohue JH, Reynolds C et al. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 2003; 138: 482-488.
20. Badgwell BD, Povoski SP, Abdessalam SF et al. Patterns of recurrence after sentinel lymph node biopsy for breast cancer. Ann Surg Oncol 10: 376-380.
21. Naik AM, Fey J, Gernignani M et al. The risk of relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection. Ann Surg 2004; 240: 462-471.
22. Winchester DJ, Sener SF, Brinkman EM et al. Axillary recurrence following sentinel node biopsy. Ann Surg Oncol 2004; 11: S58.
23. Janssen CMM, Smidt ML, Bruggink EDM et al. Axillary recurrences after negative sentinel node biopsy for breast cancer: Incidence and clinical significance. Ann Surg Oncol 2004; 11: S76.
24. Van der Vegt B, Doting MH, Jager PL et al. Axillary recurrence after sentinel lymph node biopsy. Eur J Surg Oncol 2004; 30: 715-720.
25. Torrenga. H, Fabry H, Van der Sljp JR et al. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: A long term follow up analysis. J Surg Oncol 2004; 88: 4-8.
26. Swenson KK, Mahipal A, Nissen W et al. Axillary disease recurrence after sentinel lymph node dissection for breast carcinoma. Cancer 2005; 104: 1834-1839.
27. Zavagno G, Carcoforo P, Franchini Z et al. Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection. A study on 479 breast cancer patients. Eur J Surg Oncol 2005; 31: 715-720.
28. Langer I, Mard WR, Guller U et al. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: Prospective analysis of 150 patients after SLN biopsy. Ann Surg 2005; 241: 152-158.
29. Kokke MC, Jannink I, Barneveld PC et al. Incidence of axillary recurrence in 113 sentinel node negative breast cancer patients: A 3-year follow up study. Eur J Surg Oncol 2005; 31: 221-225.
30. Jeruss JS, Winchester DJ, Sener SF et al. Axillary recurrence after sentinel node biopsy. Ann Surg Oncol 2005; 12: 34-40.
31. Palesty JA, Foster JM, Hurd TC at al. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer. J Surg Oncol 2006; 93: 129-132.
32. Takei H, Suemasu K, Kurosumi M et al. Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer. Breast cancer 2007; 14: 16-24.
33. Heuts EM, van der Ent FW, Hulsewe KW et al. Incidence of axillary recurrence in 344 sentinel node negative breast cancer patients after intermediate follow up, A prospective study into the accuracy of sentinel node biopsy in breast cancer patients. Acta Chir Belg 2007; 107(3): 279-283.
34. Bergkvist L, de Boniface J, Jönsson PE et al. Axillary recurrence rate after negative sentinei node biopsy in breast cancer. Ann Sung 2008; 247: 150-156.
35. Fisher B, Jong-Hyeon J, Anderson S et al. Twenty-five year follow up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002; 347: 567-575.